Gregg Lapointe - Jun 9, 2022 Form 4/A - Amendment Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Gregg Anthony LaPointe
Stock symbol
ATXS
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/21/2022, 08:32 AM
Date Of Original Report
Jun 9, 2022
Previous filing
May 23, 2022
Next filing
Nov 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +8.33K $0.00 8.33K Jun 9, 2022 Common Stock 8.33K $3.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being made to show the correct price of $3.00. An incorrect price of $2.99 was previously reported.
F2 This option was granted on June 9, 2022 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.